154 | CLINICAL IMPACT OF UNTARGETED BASELINE PLASMA METABOLOMICS IN NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMAR. Dondolin, Riccardo Moia, Denise Marradi et al.|Hematological Oncology|2025Cited by 0
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trialRiccardo Moia, Monica Balzarotti, Valentina Tabanelli et al.|Blood Advances|2026Cited by 0